ArticleBiochemical and biophysical research communications2022
Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19.
Davoud Ghazanfari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it